These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3986005)

  • 1. The effect of glucocorticoids on bone mass in rheumatoid arthritis patients. Influence of menopausal state.
    Als OS; Gotfredsen A; Christiansen C
    Arthritis Rheum; 1985 Apr; 28(4):369-75. PubMed ID: 3986005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic validity of local and total bone mineral measurements in postmenopausal osteoporosis and osteoarthritis.
    Nilas L; Gotfredsen A; Riis BJ; Christiansen C
    Clin Endocrinol (Oxf); 1986 Dec; 25(6):711-20. PubMed ID: 3652471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of low dosage glucocorticoids on bone mass in rheumatoid arthritis: a cross-sectional and a longitudinal study using single photon absorptiometry.
    de Deuxchaisnes CN; Devogelaer JP; Esselinckx W; Bouchez B; Depresseux G; Rombouts-Lindemans C; Huaux JP
    Adv Exp Med Biol; 1984; 171():209-39. PubMed ID: 6609542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The negative bone effects of the disease and of chronic corticosteroid treatment in premenopausal women affected by rheumatoid arthritis.
    Fassio A; Idolazzi L; Jaber MA; Dartizio C; Viapiana O; Rossini M; Gatti D
    Reumatismo; 2016 Sep; 68(2):65-71. PubMed ID: 27608794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between local and total bone mineral in patients with rheumatoid arthritis and normal subjects.
    Skibsted Als O; Gotfredsen A; Christiansen C
    Clin Rheumatol; 1983 Sep; 2(3):265-71. PubMed ID: 6678700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of risk factors for osteoporosis is dependent on gender and menopause in rheumatoid arthritis.
    Oelzner P; Schwabe A; Lehmann G; Eidner T; Franke S; Wolf G; Hein G
    Rheumatol Int; 2008 Sep; 28(11):1143-50. PubMed ID: 18446340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total and local bone mineral during estrogen treatment: a placebo controlled trial.
    Gotfredsen A; Riis BJ; Christiansen C
    Bone Miner; 1986 Apr; 1(2):167-73. PubMed ID: 3334206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does low-dose and short-term glucocorticoids treatment increase the risk of osteoporosis in rheumatoid arthritis female patients?
    Korczowska I; Olewicz-Gawlik A; Trefler J; Hrycaj P; Krzysztof Łacki J
    Clin Rheumatol; 2008 May; 27(5):565-72. PubMed ID: 17909741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of decreased bone mass in rheumatoid arthritis. Relation to anti-inflammatory treatment.
    Als OS; Christiansen C; Hellesen C
    Clin Rheumatol; 1984 Jun; 3(2):201-8. PubMed ID: 6467862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dual-photon absorptiometry: a new method of determining bone mineral content. I. Basic principles].
    Buttermann G; Eiber J; Hennig J; Pabst HW
    Nuklearmedizin; 1988 Feb; 27(1):12-8. PubMed ID: 3368331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex hormones and bone metabolism in postmenopausal rheumatoid arthritis treated with two different glucocorticoids.
    Montecucco C; Caporali R; Caprotti P; Caprotti M; Notario A
    J Rheumatol; 1992 Dec; 19(12):1895-900. PubMed ID: 1294736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteocalcin and bone mineral content in rheumatoid arthritis.
    Peretz A; Praet JP; Rozenberg S; Bosson D; Famaey JP; Bourdoux P
    Clin Rheumatol; 1989 Mar; 8(1):42-8. PubMed ID: 2787225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin.
    Tascioglu F; Colak O; Armagan O; Alatas O; Oner C
    Rheumatol Int; 2005 Nov; 26(1):21-9. PubMed ID: 15688191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral content in patients with rheumatoid arthritis: relationship to low-dose steroid therapy.
    Butler RC; Davie MW; Worsfold M; Sharp CA
    Br J Rheumatol; 1991 Apr; 30(2):86-90. PubMed ID: 2012961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Representativity of regional to total bone mineral in healthy subjects and 'anticonvulsive treated' epileptic patients. Measurements by single and dual photon absorptiometry.
    Gotfredsen A; Borg J; Nilas L; Tjellesen L; Christiansen C
    Eur J Clin Invest; 1986 Jun; 16(3):198-203. PubMed ID: 3089816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total body bone mineral in healthy adults.
    Gotfredsen A; Hadberg A; Nilas L; Christiansen C
    J Lab Clin Med; 1987 Sep; 110(3):362-8. PubMed ID: 3611957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical markers of bone turnover in rheumatoid arthritis. Relation to anti-inflammatory treatment, sex, and menopause.
    Als OS; Riis BJ; Gotfredsen A; Christiansen C; Deftos LJ
    Acta Med Scand; 1986; 219(2):209-13. PubMed ID: 3485890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rates of bone loss in normal women: evidence of accelerated trabecular bone loss after the menopause.
    Nilas L; Christiansen C
    Eur J Clin Invest; 1988 Oct; 18(5):529-34. PubMed ID: 3147906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids.
    Sambrook PN; Eisman JA; Yeates MG; Pocock NA; Eberl S; Champion GD
    Ann Rheum Dis; 1986 Nov; 45(11):950-3. PubMed ID: 3789829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice.
    Solomon DH; Katz JN; Jacobs JP; La Tourette AM; Coblyn J
    Arthritis Rheum; 2002 Dec; 46(12):3136-42. PubMed ID: 12483716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.